NORMA Group’s Investor Relations activities seek to further increase awareness of the company on the capital market, strengthen confidence in its share in the long term and to achieve a fair valuation of the company.

Maintaining an ongoing, transparent dialogue with analysts represents one key element of Investor Relations work. Eleven national and international research firms and institutions currently follow the development of the NORMA Group share and submit their valuations at regular intervals. As of the end of July 2023, four of them rated the NORMA Group share as a “buy” while seven analysts recommended holding the share. The average target price was EUR 20.77 (Dec 31, 2022: EUR 25.08).

As of July 31, 2023